Abstract: ␣ 1 -Acid glycoprotein (AGP) is a major acute-phase protein present in human plasma as well as in polymorphonuclear leukocytes (PMN). In this report, we show that PMN synthesize a specific glycoform of AGP, which is stored in the specific and azurophilic granules. Activation of PMN results in the rapid release of soluble AGP. PMN AGP exhibits a substantially higher apparent molecular weight than plasma AGP (50 -60 kD vs. 40 -43 kD), owing to the presence of strongly fucosylated and sialylated polylactosamine units on its five Nlinked glycans. PMN AGP is also released in vivo from activated PMN, as appeared from studies using well-characterized myocard slices of patients that had died within 2 weeks after an acute myocardial infarction. AGP was found deposited transiently on damaged cardiomyocytes in areas with infiltrating PMN only. It is interesting that this was inversely related to the deposition of activated complement C3. Strongly fucosylated and sialylated AGP glycoforms have the ability to bind to E-selectin and to inhibit complement activation. We suggest that AGP glycoforms in PMN provide an endogenous feedback-inhibitory response to excessive inflammation. J. Leukoc. Biol. 77: 000 -000; 2005.
INTRODUCTION
The acute-phase response involves local and systemic reactions, which serve to limit tissue damage and to restore homeostasis after infection or tissue injury [1, 2] . The influx of polymorphonuclear cells (PMN) into inflamed tissues is one of the early, local responses, a P-and E-selectin-dependent process [3, 4] . PMN are equipped with a broad range of compounds that are stored in various types of granules [5] . These compounds are rapidly released from PMN once infiltrated into the inflamed area and serve to assist in the combat against pathogens and the removal of damaged cells. Complement activation fragments are formed in the inflamed area, such as C5a, and direct the infiltration of PMN. These fragments are supposed to promote ongoing tissue damage by stimulating the infiltration and activation of PMN [6] . One of the systemic inflammatory reactions is the hepatic acute-phase response, which involves the increased synthesis of a set of serum proteins with anti-inflammatory properties, the acute-phase proteins [1, 2, 7, 8] . It is assumed that the function of these proteins is to dampen the side-effects of the local inflammatory reactions and to prevent a progression to chronic inflammation [2] , although some acute-phase proteins may stimulate inflammation and tissue damage as well [9] . ␣ 1 -Acid glycoprotein (AGP), also known as orosomucoid, is one of the major acutephase glycoproteins. Human plasma AGP contains five Nlinked complex-type glycans, which are strongly sialylated and comprise about half of its molecular mass [10, 11] . The hepatic acute-phase response induces an increased ␣3-fucosylation of these glycans, resulting in the occurrence of AGP glycoforms rich in sialyl Lewis x groups in plasma during inflammation [12] . It is interesting that these AGP glycoforms, by binding to E-selectin [13] and by amelioration of complement-induced damage [14] , possibly counteract the influx of PMN in inflamed tissue.
Most acute-phase proteins are produced in the liver. It is remarkable that a number of acute-phase proteins are also present in resting PMN [15] [16] [17] [18] . AGP is one of them; a membrane-associated as well as an intracellular-localized form has been described for PMN [15, 17] . The glycosylation process in PMN gives rise to polyfucosylated and sialyl Lewis x -expressing glycans on its cell-surface glycoproteins, which may constitute specific ligands for E-and P-selectin [19, 20] . AGP produced by PMN would contain similar glycans [21] and hence, may serve as an endogenous feedback inhibitor of excessive recruitment of PMN by activated complement factors and the selectindependent processes.
In this study, we provide biochemical and electron-microscopical evidence that PMN have AGP, which is secreted rapidly upon activation in vitro as well as in vivo in patients that had died of acute myocardial infarction (AMI) [22] .
MATERIALS AND METHODS

Materials
Desalting and affinity HiTrap columns were purchased from Pharmacia (Uppsala, Sweden). Monoclonal mouse anti-human AGP (mAb-anti-AGP) immunoglobulin G (IgG; 6 mg; G9, a kind gift of Dr. H. Brian Halsall, University of Cincinnati, OH) was immobilized onto a 1-ml HiTrap column (mAb-anti-AGP affinity column). Monospecific rabbit anti-human AGP antiserum was obtained from Dakopatts A/S (Glostrup, Denmark), and rabbit anti-human lactoferrin was from Cappel Laboratories (Cochranville, PA). Rabbit anti-human albumin and mouse mAb against human myeloperoxidase (MPO) were from Sanquin (Amsterdam, the Netherlands). C3-9 (IgG1 subclass) against activated complement factor C3 and B13.9 against CD66b (granule marker) have been used previously for immunohistochemical studies [22] . 6H3, a mAb against diand/or trimeric Le x structures [23] , was a kind gift of Dr. B. Appelmelk (University of Amsterdam, the Netherlands). Immortalized human hepatocytes (IHH) were a kind gift of Dr. H. Moshage (University of Groningen, the Netherlands) [24] . Other materials were obtained from commercial sources as described previously [12, 25] .
Patients and processing of tissue specimens
Patients, referred to the Department of Pathology, VU University Medical Centre (Amsterdam, the Netherlands) for autopsy, were included in this study when at autopsy, performed within 24 h following death, they showed signs of a recently developed AMI, as has been described in more detail in earlier studies [22, 26] . Permission to use material left over (including fetal material), after the usual diagnostic process has been completed, is part of the standard patient contract in our hospital. Tissue specimens were obtained from the infarcted area (i.e., the area with decreased lactate dehydrogenase staining) as well as from the adjacent, noninfarcted myocardium (internal control) of 27 patients. Infarct age, assessed by microscopical criteria [27, 28] , varied from less than 12 h up to 2 weeks: Ͻ12 h (nϭ2), 12-24 h (nϭ5), 1-3 days (nϭ10), 5-9 days (nϭ3), and 9 -14 days (nϭ2). The further characteristics of the patients are supplied in supplementary data to this paper. Before being prepared as cryosections, the tissue specimens were stored at -196°C (liquid N 2 ).
Localization of AGP, di-and/or trimeric Le x structures, activated C3, and CD66b
Four m-thick frozen sections were mounted onto glass slides, dried for 1 h by exposure to air, and fixed in acetone ("Baker Analyzed Reagent," Mallinckrodt Baker BV, Deventer, Holland). The slides were incubated at room temperature for 10 min with normal rabbit serum (Dakopatts A/S), 1:50 diluted in phosphate-buffered saline (PBS) containing 1% (w/v) bovine serum albumin (BSA) after a rinse in PBS. Incubation of the slides with specific antibody solutions was performed for 60 min at room temperature (G9 diluted 1:300 in PBS-BSA; C3-9 diluted 1:1000 in PBS-BSA; CD66b diluted 1:1000 in PBS-BSA; 6H3 diluted 1:300 in PBS-BSA). As control, irrelevant mAb IgG 1 and mouse myeloma protein (Cappel, Organon Teknika, Turnhout, Belgium) were tested as well. After washing with PBS, slides were incubated with horseradish peroxidase-conjugated rabbit anti-mouse Ig (Dakopatts A/S), 1:25 diluted in PBS-BSA. Thereafter, the slides were washed again in PBS and incubated for 4 min in 0.5 mg/ml 3,3Ј-diaminobenzidine-tetrahydrochloride (Sigma Chemical Co., St. Louis, MO) in PBS (pH 7.4), containing 0.01% (v/v) H 2 O 2 , washed again, counterstained with hematoxylin for 40 s, dehydrated, cleared, and finally, mounted. Microscopic criteria were used to estimate infarct duration in all myocardial tissue specimens [27, 28] , as described in more detail in earlier studies [22, 26] . Two independent investigators (H. W. M. Niessen and R. Nijmeyer) performed these microscopic studies; for the final scoring results, two investigators achieved consensus.
Quantification of the immunohistochemical deposition of complement C3, CD66b, and AGP and statistical treatment
The extent of depositions of C3, CD66b, and AGP was determined as follows: The slides were analyzed at magnification 25ϫ and divided in at least four parts. For each part of the slide, the percentage of positivity for the specific antibodies was analyzed. Subsequently, the average of positivity of the whole slide was calculated.
Data were analyzed with the statistical program SPSS for Windows, version 9.0 (SPSS Inc., Chicago, IL). The Mann-Whitney U-test was used to evaluate the significance of differences. A P value of Ͻ0.05 was considered to represent a significant difference.
Processing of myocardial tissue specimens for analysis of AGP mRNA
Myocardial tissue specimens from a patient, dead from a cause not related to myocardial infarction, were obtained within 12 h after decease. Specimens, taken from the left ventricle of the heart, were trimmed free of other tissue, minced into smaller pieces, and subsequently, incubated for 30 min at 37°C in a collagenase buffer (118 mM NaCl, 2.6 mM KCl, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 25 mM NaHCO 3 , 11.1 mM glucose) containing 4.7 M CaCl 2 and collagenase (Worthington type II, 121 U/ml). Thereafter, cells were strained through a cell dissociation mesh size 100 (Sigma Chemical Co.). Cells recovered consisted of Ͼ95% cardiomyocytes. These cells were stored at -80°C.
Processing of tissue specimens for isolation of AGP from infarcted and noninfarcted myocardial tissue
Specimens from infarcted and noninfarcted myocardial areas were homogenized using a Dysmembranator in Veronal buffer (0.01 M CaCl 2 , 0.02 M MgCl 2 , 0.01 M sodium diethylbarbital, 0.65 M NaCl, pH 7.4). The homogenate was centrifuged (10,000 g, 20 min), and the supernatant was used for isolation of AGP. All procedures were performed at 4°C.
AGP mRNA expression
Total RNA was extracted from PMN, cardiomyocytes, and IHH, as described by Chomczynski and Sacchi [29] . For polymerase chain reaction (PCR), cDNA was synthesized from 4 g total RNA by using the 3Ј rapid amplification of 3Ј cDNA ends system from Gibco, Life Technologies (Grand Island, NY). cDNA corresponding to 80 ng RNA template was used for PCR analysis. PCR reactions were performed in a final volume of 50 l containing: Taq buffer (Promega, Madison, WI), 1.5 mM MgCl 2 , 0.2 mM deoxy-unspecfied nucleoside 5Ј-triphosphate each (Boehringer Mannheim, Mannheim, Germany), 1.25 units TaqBeads Hot Start polymerase (Promega), and 50 pmol each primer (Isogen, ). Human plasma AGP is encoded by three genes: AGP-A, AGP-B, and AGP-BЈ; the latter two are identical and are further referred to as AGP-B/BЈ [30] . The sense primer sequences defined for AGP-A and AGP-B/BЈ were GACCAGTGCATCTATAACACCACC and TGATGTTTGGTTCCTACCTG-GAC, respectively; the antisense primer sequence GTTCCAAACACA-GAAGCTTTATTG was used for AGP-A and AGP-B/BЈ [30] . For actin, the sense primer TGACGGGGTTCACCCACACTGTGCCCATCT and the antisense primer AGTCATAGTCCGCCTAGAAGCATTTGC were used as a positive control. Amplifications were carried out for 40 cycles using the following conditions: 1 min at 60°C, 1.5 min at 72°C, and 1 min at 94°C. PCR products were fractionated by electrophoresis in 1.5% (w/v) agarose gels. Quantitative real-time PCR reactions were performed with the SYBR Green method in an ABI 7900HT sequence detection system (Applied Biosystems, Foster City, CA) as detailed elsewhere [31] using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a reference gene. The thermal profile for all the reactions was 2 min at 50°C, followed by 10 min at 95°C, and then 40 cycles of 15 s at 95°C and 1 min at 60°C. The fluorescence monitoring occurred at the end of each cycle. Specific primers were designed for these reactions by using the com-puter software Primer Express 2.0 (Applied Biosystems) [31] . The sense primers used for AGP-A, AGP-B/BЈ, and GAPDH were CGTGCCTCCTG-GTCTCAGTATG, AGAGTACCAGACCCGCCAGAAC, and CCATGTTCGT-CATGGGTGTG, respectively; the antisense primers were AAACCACTTGC-CAGTGATCCG, CCAGGTAGGAACCAAACATCA, and GGTGCTAAG-CAGTTGGTGGTG, respectively. Data were expressed as the normalized amount of the AGP-A and AGP-B/BЈ gene (Nt) with respect to the expression of the endogenous reference GAPDH gene, using the formula Nt ϭ 2 -( Ct AGP -Ct GAPDH ) [32] . The Ct value is defined as the number of PCR cycles where the fluorescence signal exceeds the detection threshold value, which was fixed as 10 times the standard deviation of the fluorescence during the first 15 cycles and typically corresponds to 0.2 relative fluorescence units.
PMN isolation and stimulation
PMN were purified from the pooled buffy coats of blood [anticoagulated with 0.4% (w/v) trisodium citrate (pH 7.4)] obtained from 20 healthy volunteers by density gradient centrifugation in isotonic Percoll and lysis of the contaminating erythrocytes, by incubation with ice-cold isotonic ammonium chloride [33] .
Prior to the preparation of PMN cDNA, the cells were further purified by cell sorting for CD15 ϩ /CD16 -cells as well as on scatter. Stimulation experiments with PMN were performed as described by Kuijpers et al. [33] . In short, PMN (10ϫ10 6 /ml in Hepes medium) were preincubated in a shaking water bath at 37°C for 5 min, before incubation in the presence of cytochalasin B (CytoB; 5 g/ml, 2 min) or platelet-activating factor (PAF; 1 M, 5 min) and further stimulation with f-Met-Leu-Phe (fMLP; 1 M, 15 min) at 37°C. Reactions were stopped by centrifugation (5 min, 800 g), and pellets and supernatants were stored at -80°C until further analysis.
Cryoimmunogold electron microscopy
Bone marrow cells and PMN from peripheral blood were prepared and fixed as described earlier by Kuijpers et al. [33] . Ultrathin, frozen sections were incubated at room temperature with the indicated antibodies and 10-and/or 15-nm protein-A-gold [34] . After immunolabeling, cryosections were embedded in a mixture of methylcellulose and uranyl acetate and were examined with a Philips CM 10 electron microscope (Eindhoven, the Netherlands). As a control, the primary antibody was replaced by an irrelevant murine or rabbit antiserum.
AGP isolation and molecular weight analysis PMN (400ϫ10 6 ) were incubated for 10 min at 0°C in 5 ml 50 mM Tris-HCl (pH 8), supplemented with a protease inhibitor mixture (Boehringer Mannheim) and 1% (w/v) Triton X-100, followed by centrifugation (14,000 g; Eppendorff centrifuge) for 30 min at 4°C. The obtained cell extract was stored at -20°C until further use. Extracts of 3.6 ϫ 10 6 isolated human cardiomyocytes were obtained in the same way. AGP was isolated from the various sources by affinity chromatography on a 1-ml mAb-anti-AGP HiTrap column [25] . AGP concentrations were determined by single radial immunodiffusion according to Mancini et al. [35] , using polyclonal rabbit anti-human AGP IgG for detection. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE; 10%) of 50 ng AGP, followed by blotting on nitrocellulose and detection of AGP by immunostaining with polyclonal rabbit anti-human AGP IgG [12] , was used to assess the apparent molecular weights.
Studies toward the nature, soluble and/or membrane-bound, of AGP in PMN Preparations of 10 8 PMN of various donors were subjected to seven freeze-thaw cycles in a final volume of 5 ml PBS containing a protease-inhibitor mixture. Between each cycle, the cells were passed through a 0.15-mm needle. The final preparation was centrifuged for 1 h at 100,000 g in a MSE Pegasus centrifuge at 4°C, and pellets and supernatant were collected. The pellets were extracted for 30 min with 5 ml 1% 3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate in PBS supplemented with protease inhibitors. AGP was isolated from the extract and the 100,000 g supernatant, by addition of a 0.1-ml suspension of Sepharose beads containing immobilized mAb-AGP C9 in PBS (1:1, v/v), followed by incubation in a rotating device overnight at 4°C. AGP bound to the beads was detected by 10% SDS-PAGE subsequent blotting and AGP detection, by polyclonal rabbit anti-human AGP IgG after incubation of the beads for 10 min at 100°C in 0.1 ml Laemmli sample buffer supplemented with ␤-mercaptoethanol [12] .
N-Glycosidase F (PNGase F) treatment and monosaccharide analysis
Approximately 100 g AGP, isolated in triplicate from PMN or normal human plasma, was treated with PNGase F to release the N-linked glycans. Incubations were carried out under reducing conditions in 100 l 50 mM sodium phosphate buffer, 1% (w/v) Nonidet P-40, and 1000 U PNGase F for 1 h at 37°C. Short incubation times with PNGase F (tϭ0.5, 1, and 5 min) were used to obtain partial release of glycans to assess the number of glycans per molecule. Aliqots (50 ng) of AGP were treated and subjected to SDS-PAGE gels with subsequent blotting as described above. Monosaccharide analysis of acid hydrolysates of PNGase F-released glycans was performed by high pH anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) [25] .
RESULTS
Characteristics of PMN AGP
Lysates of nonstimulated PMN contained 0.42 g AGP per 10 6 cells, as assessed by radial immunodiffusion assay. The majority of the AGP molecules detected by SDS-PAGE and immunoblotting exhibited an apparent molecular weight of 50 kD to over 60 kD (Fig. 1) . A minor fraction of AGP was detected at 41-43 kD, the apparent molecular weight generally found for human plasma AGP (Fig. 1) [10, 13] . Both AGP variants appeared to be present as soluble proteins in PMN, as they were recovered almost completely in the 100,000 g supernatant of cells that were lysed by repeated freezing and thawing (Fig. 1d) . In monocytes, only plasma-type AGP was detectable, which also appeared to be present as a soluble molecule in these cells.
PNGase F digestion revealed that the difference in molecular weight relied in the type of glycosylation of the molecules (Fig. 1a) . Treatment for up to 5 min resulted in a timedependent appearance and vanishing of four lower molecular weight bands and the appearance of a 23-kD band, representing the AGP aglycon, being indicative for the presence of five N-linked, complex-type glycans in both AGP preparations [10, 25] . Of the two AGP preparations, only PMN AGP stained positively with the monoclonal 6H3 directed against di-or trimeric Lewis X groups (Fig. 1b, lanes 4 -7) . These findings indicated that the external branches of the N-linked glycans of PMN AGP were composed of fucosylated polylactosamine units. This was further supported by the monosaccharide content of the two AGP preparations when expressed per three mannose residues, i.e., per N-linked glycan ( Table 1 ). The 8.1 galactose, 6.6 fucose, and 10.1 N-acetylglucosamine residues per glycan of PMN AGP were in support to the presence of several lactosamine units (Gal-GlcNAc sequences) per external branch of each glycan, of which the majority is fucosylated. The monosaccharide composition of plasma AGP reflected the well-documented presence of tri-and tetra-antennary N-linked glycans, which do not express considerable amounts of polylactosamine units (i.e., Gal-GlcNAc extensions) [10, 11, 25] . The sialic acid content of 2.1 residues per glycan was lower than that of plasma AGP (Table 1) . This suggested incomplete sialylation of the glycans, which was consistent with the lower electrophoretic mobility of part of the PMN AGP molecules relative to plasma AGP in immunoelectrophoresis (not shown). The low amount of sialic acid per glycan did not reflect the presence of diantennary glycans, as no reactivity was detected with concanavalin A, which reacts with this type of glycans present on normal AGP [36] .
Expression of AGP mRNA
Three adjacent genes, AGP-A, AGP-B, and AGP-BЈ, are clustered in one locus of the human genome, of which the latter two are identical and are further referred to as AGP-B/BЈ [30] . The genes encode for the two molecular forms of AGP present in serum, which differ in 21 out of the 181 amino acids [30] . Expression of the AGP-A and AGP-B/BЈ genes in PMN was clearly established by quantitative real-time PCR analysis of PMN-cDNA. The relative abundance of AGP-A and AGP-B/BЈ mRNA, using GAPDH as the endogenous reference gene, was 0.094 Ϯ 0.20 and 0.020 Ϯ 0.005 (nϭ4), respectively. A higher expression of AGP-A mRNA over AGP-B/BЈ mRNA was also found for the hepatic mRNA [relative abundance to GAPDH, 10.7 Ϯ 2.3 and 4.3Ϯ0.9 (nϭ4), respectively], which is in accordance with literature [30] .
Release of AGP from PMN by degranulation
Nonstimulated PMN did not release AGP spontaneously, as it was not detectable in the extracellular medium of the nonstimulated PMN (Fig. 1c) . Degranulation of specific and azurophilic granules of PMN in vitro takes place in the order: CytoB ϩ fMLP (both type of granules) Ͼ PAF ϩ fMLP (specific granules) Ͼ fMLP alone [33] . Stimulation of PMN with CytoB ϩ fMLP resulted in a maximal and total release of soluble AGP into the medium (Fig. 1c) . Stimulation with PAF ϩ fMLP resulted in a diminished release and with fMLP alone, in a minimal release of AGP into the extracellular medium (Fig. 1c) .
Subcellular localization of AGP in PMN
Immunoelectron microscopy showed that AGP was localized in electron-dense granules of PMN and not on the cell membrane (Fig. 2a) . To characterize the AGP-positive granules, cryosections were double-labeled with anti-AGP IgG and antibodies against lactoferrin, a marker for PMN-specific granules (Fig.  2b) , MPO, a marker for PMN azurophilic granules (Fig. 2c) , and albumin, a marker for secretory vesicles and multivesicular bodies (Fig. 2d) [6] . Almost all AGP-positive granules were also lactoferrin-labeled (Fig. 2b) , whereas only a few AGPpositive granules were MPO-positive (Fig. 2c) . Colocalization of AGP was also found with albumin in the secretory vesicles.
To study whether AGP was also synthesized in PMN during their maturation, the distribution of AGP was investigated in 1 and 4) or from patients suffering from acute trauma (lanes 2 and 5) and of PMN AGP (lanes 3 and 6) were immunostained with rabbit anti-human AGP IgG or the diand/or trimeric Lewis X -specific antibody 6H3. Lane 7, Trimeric Lewis X -albumin conjugate, a positive control for 6H3 [23] . (c) AGP secretion by activated PMN. AGP present in PMN extracts and in extracellular medium without and with stimulation by CytoB ϩ fMLP, PAF ϩ fMLP, or fMLP alone, as indicated in the table and a; immunoprecipitated AGP from human plasma was used as a control. (d) Distribution of AGP over 100,000 g supernatant (Sup) and extract of the residual pellet of PMN and monocytes after lysis by repeated freezing and thawing. The extract of the pellet was set at the same volume as the supernatant prior to immunoprecipitation. Immunoprecipitated AGP from human plasma was used as a control. The analyses were performed by HPAEC-PAD on acid hydrolysates of purified AGP obtained from PMN and serum as described in Materials and Methods. Data are expressed as mol monosaccharide per 3 mole mannose to reveal the mean number of residues per N-linked glycan. The data represent the means of three independent analyses with a variance of less than 5%. PMN progenitors obtained from bone marrow. Cryosections were double-labeled with anti-AGP and antilactoferrin or anti-MPO antibodies, respectively. A few promyelocytes containing only MPO-positive granules were detected; some of these were also positive for AGP (not shown). Myelocytes were abundant and contained specific granules double-labeled for lactoferrin and AGP; both labels were also found on endoplasmic reticulum and Golgi stacks (Fig. 3) . These results strongly suggested that AGP is synthesized during maturation of PMN. No labeling was found in the controls of each experiment, where the primary antibody was replaced by a nonrelevant murine or rabbit antiserum (not shown).
Transient deposition of AGP, di-and/or trimeric Le x structures, CD66b, and activated C3 in infarcted human myocardium Tissue specimens were obtained from 27 patients who had died after an AMI event that had occurred less than 12 h, up to 2 weeks before death (see Materials and Methods). AGP staining was only found in infarcted myocardium, exclusively in the areas were PMN, detected by CD66b, were found (Fig. 4, a  and b) . AGP was present on jeopardized cardiomyocytes (Fig.  4a) , but also some weak staining was found on PMN. Endothelium in the infarcted area also stained now and then for AGP (results not shown), which on cardiomyocytes, was only found in infarctions when PMN were also present and showed maximal deposition in 1-to 3-day-old infarcts (Fig. 4d) . AGP staining on cardiomyocytes was most intense at the plasma membrane, although sometimes, staining of cytosol and crossstriations was found (not shown). The AGP-positive areas occurred in most of the patients within the center zone of larger infarction sites.
As recently shown, activated complement factor 3 (C3) was found localized on jeopardized cardiomyocytes in the infarcted myocardium (Fig. 4c) [26] . It is remarkable that the intensity of staining of activated C3 was inverse to that of AGP: C3 staining was more intense in the surrounding border zone (cells that are still positive in the area between complement-positive and -negative areas [26] ) than in the center zone (cf., Fig. 4, a and  c) . Also, di-and/or trimeric Lewis X structures bound to cardiomyocytes were found in the infarcts. Their localization matched with that of AGP (Fig. 5) . However, in contrast to AGP, di-and/or trimeric Lewis X structures were also found on PMN in the infarcts (Fig. 5, b and d) . The latter is in agreement with the idea that di-and trimeric Lewis X structures are present on PMN glycoproteins [19, 37] .
Staining of the myocardial tissue specimens with isotopematched, control antibodies yielded negative results (not shown). Also, internal controls, i.e., specimens taken from noninfarcted sites of the myocardium of the same patient, did not stain for AGP, CD66b, di-and/or trimeric Lewis X structures, or activated C3. Furthermore, myocardial tissue specimens from an immature, spontaneously aborted fetus, which died in utero at an amenorrhoea duration of 22 weeks and were regarded to represent a pure, nonischemic myocardial control, also did not show any staining for AGP, CD66b, di-and/or trimeric Lewis X structures, and activated C3 (not shown). Neither staining of these antibodies was found in hearts (nϭ3) of adult patients that died to a cause not related to acute myocardial infarction (not shown). Different molecular weight forms of AGP in infarcted and noninfarcted myocardial tissue AGP was isolated from homogenates of infarcted and noninfarcted myocardial tissue and subjected to SDS-PAGE and blotting. Plasma AGP was present in homogenates of both sources of tissue (Fig. 6a, lanes 1-3, heavy band ). An additional, higher molecular weight AGP band was present in the homogenate of the infarcted area, most probably representing PMN AGP (Fig. 6a, lanes 1 and 4) . This band was not detectable in the noninfarcted tissue (lane 2) and in normal plasma (lane 3).
Lack of AGP mRNA expression in cardiomyocytes
Despite a high levels of actin mRNA, no expression of the two genes for AGP, AGP-A, and AGP-B/BЈ [30] was detected in lysates of cardiomyocytes obtained from normal myocardial tissue (Fig. 6b, lanes 1-3) . IHH used as a positive control expressed the AGP-A (461 bp) and AGP-B/BЈ genes (341 bp) in addition to actin (Fig. 6b, lanes 4 and 5) .
DISCUSSION
In this report, we demonstrate that PMN synthesize and upon in vitro activation, secrete a strongly fucosylated AGP glyco- form, which differs in molecular weight and glycosylation from plasma AGP. Furthermore, we provide immunohistochemical and biochemical evidence for the presence of a specifically fucosylated AGP glycoform in infarcted myocardium originating from infiltrating PMN. The AGP molecules are transiently deposited on jeopardized cardiomyocytes in areas high in infiltrating PMN and low in activated complement factor C3.
AGP was mainly present in specific granules but also in secretory granules and in some azurophilic granules of PMN, as was clear from electron microscopic observations in PMN and PMN progenitors from bone marrow (Figs. 2 and 3) . This is supported biochemically by the difference in effects of CytoB and PAF on the secretion of AGP by fMLP-stimulated PMN (Fig. 1c) . Gahmberg and Andersson [15] have reported that AGP was present as a membrane-bound form on PMN. Our studies show that AGP was present in PMN as a soluble molecule (Fig. 1d) and was recovered as such from the secretion media after activation (Fig. 1c) . A possible explanation for this discrepancy may be that the specific sialylated and fucosylated glycan structures of PMN AGP can bind to cell-surface L-selectin molecules. When so, stimulation of PMN will result in the rapid proteolytic release of L-selectin and then also will release bound AGP. Alternatively, the G9 mAb that was used in the present study, which is directed against the C-terminal part of AGP, may not recognize a membrane-bound isoform of AGP. De novo synthesis of AGP by PMN was indicated by its presence in the rough endoplasmic reticulum and Golgi stacks of PMN progenitors from bone marrow (Fig. 3) . This was further supported by the expression of the two AGP mRNAs in PMN, and AGP-A was more strongly expressed than AGP-B/BЈ, as in human hepatocytes [30] .
The molecular weight of PMN AGP was higher than that of plasma AGP, 50 -60 kD versus 40 -43 kD. Only a minor fraction of AGP in PMN might have originated from plasma, as is indicated by the colocalization with albumin in secretory vesicles (Fig. 2d) as well as by the weak appearance of an AGP band at the same molecular weight as plasma AGP in Figure 1 . The difference in molecular weight between PMN and plasma AGP appeared to reside in the presence of strongly fucosylated polylactosamine units on the five N-linked glycans of PMN AGP (Fig. 1, a and b, Table 1 ). This further supports synthesis of AGP by PMN, as the type of glycosylation is typical for PMN [19, 37] . Like in the studies of Fukuda and co-workers [19, 37] , the glycans appeared to be undersialylated, as indicated by the lower sialic acid/mannose ratio (Table 1) as well as the observed lower electrophoretic mobility of PMN AGP in relation to normal plasma AGP (not shown). Most probably, the glycans were of the tri-or tetra-antennary type, as was indicated by the observed lack of concanavalin A reactivity of PMN AGP (not shown).
Presumably, PMN release the specifically fucosylated AGP glycoforms also in vivo, as was suggested by the immunohistochemical studies in the patients that had died from AMI. In the first place, positive staining for AGP of myocardial tissue with the mAb-anti-AGP G9 was only detected when infiltrating PMN were found to be present, i.e., only during the first few days after onset of the infarct (Fig. 4d) . AGP staining colocalized with PMN in the center zone of the infarct and was found deposited on jeopardized cardiomyocytes as well as on PMN (Fig. 4) . Second, colocalization was found on AGP and diand/or trimeric Lewis X structures (Fig. 5) . The colocalization on cardiomyocytes strongly suggests that the mAb 6H3 recognized deposited PMN AGP and not plasma AGP, as the latter does not express di-and/or trimeric Lewis X -substituted glycans (Fig. 1b, Table 1 ) [10, 11, 36] . The intense staining of PMN by di-and/or trimeric Le X is in accordance with the abundant occurrence of these structures on these cells [19] . In the third place, in tissue from an AMI, 41-43 kD and ϳ60 kD AGP was present in the myocardial infarcts, whereas in normal myocardial tissue, only 41-43 kD AGP was found (Fig. 6a) . The latter AGP most probably originated from plasma, as no AGP could be detected in purified cardiomyocytes (data not shown). Siegel et al. [38] have reported a localization of AGP at the cell surface of the cardiomyocytes in the region of the sarcolemma of normal myocardium and diminished amounts in necrotic tissue in acute myocardial infarcts. These studies were performed using polyclonal antibodies for detection. We also found abundant staining of the myofibers with commercial polyclonal antibodies against AGP (data not shown). However, we concluded that this was the result of cross-reactivity, e.g., with acid glycoproteins that are known to be present in the region of the sarcolemma [38] . This conclusion was based on the finding that cytoplasmic as well as membrane-staining with mAb-anti-AGP G9 for AGP were only found in AMI and not in normal myocardial tissue. In addition, PCR analysis of cDNA prepared from isolated and purified cardiomyocytes did not show detectable expression of AGP mRNA. Although it cannot be excluded that during AMI the conditions of hypoxia and/or ischemia have induced the biosynthesis of AGP by cardiomyocytes, we do not think that this would have resulted in the specific AGP molecules detected in the present study on those cells. On the contrary, we think that the cytoplasmic staining of AGP can be explained by the leakage of the membranes of the ischemic-jeopardized and complement-positive cardiomyocytes [26] . AGP appeared to be decorated with the typical PMN type of glycans expressing di-and/or trimeric Le X groups; no indications are presented in the literature pointing to the presence of such a type of glycans on myocardial cells.
A major stimulus for ongoing inflammation in AMI is presumably the activation of complement, resulting in an extension of the inflamed zone as well as further attraction of PMN [26] . When accumulating at high numbers, PMN may cause significant tissue damage [22] . It is interesting that the intensity of complement-staining in the AGP-positive areas during an AMI was less than that in the border zone of the infarct area, in which AGP was negative (Fig. 4) . It is tempting to speculate that less-complement depositions were a result of release of PMN AGP, as specifically fucosylated AGP glycoforms have been reported to inhibit complement activity in vitro and possibly also in vivo [14] . PMN granules contain other complement-inhibiting substances as well, such as defensins [39] .
It is not likely that the loss of complement positiveness in the center of the infarction area can be attributed to a low flow state in the reperfused heart. In a recent study in which all patients of the present study were included, we found that reperfusion therapy indeed induces larger areas of complement positiveness compared with nonreperfused hearts [40] . However, also in these reperfused hearts, the center of the infarc-tion area showed less-complement depositions similarly, as in the hearts of patients with infarctions not treated with reperfusion therapy. Furthermore, in none of the patients was an obstructive thrombus found after 1-3 days infarction, which makes it hard to believe that no reperfusion would have taken place in the infarcted area of patients who did not receive reperfusion therapy. Next to this, we and others have shown that in these infarcted areas also, complement is produced locally by endothelium, which makes it very likely that a source of complement in infarcted areas is also present, even in less-perfused areas [26, 40, 41] .
The fucosylated structures, such as expressed on PMN AGP, are suitable ligands for E-selectin [4, 20, 42] . So, PMN AGP released into the inflamed area and diffused into the blood plasma may also antagonize adhesion of newly arriving PMN directly, by neutralizing E-selectin on the inflamed endothelium. For plasma AGP, it has been reported that it is able to diffuse through the endothelium (see e.g., ref. [43] ). A masking effect of selectins was already proposed for the strongly fucosylated and sialyl Lewis X -containing AGP glycoform present in acute-phase plasma [12, 13] . Indeed, studies in an ischemiareperfusion model in rats support this notion [14] . Amelioration of PMN-induced damage was observed by injecting recombinant human AGP prior to reperfusion; a sialyl-Lewis x -containing AGP glycoform is more effective in that regard than a nonfucosylated AGP glycoform.
The exact function of AGP is not known. In addition to the above-described effects on complement and E-selectin, other anti-inflammatory effects have been reported for total AGP or specific AGP glycoforms, under inhibition of chemotactic responses of PMN to fMLP and C5a [8, 13, 44 -47] . The demonstration in this report that PMN harbor endogenously synthesized, soluble AGP, which is released upon activation, strongly suggests that PMN are equipped with a feedbackresponse mechanism to excessive inflammation.
